These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8445486)

  • 1. Ultrastructural features of fetal erythroid precursors infected with parvovirus B19 in vitro: evidence of cell death by apoptosis.
    Morey AL; Ferguson DJ; Fleming KA
    J Pathol; 1993 Feb; 169(2):213-20. PubMed ID: 8445486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parvovirus B19 and the pathogenesis of anaemia.
    Chisaka H; Morita E; Yaegashi N; Sugamura K
    Rev Med Virol; 2003; 13(6):347-59. PubMed ID: 14625883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophenotyping of fetal haemopoietic cells permissive for human parvovirus B19 replication in vitro.
    Morey AL; Fleming KA
    Br J Haematol; 1992 Oct; 82(2):302-9. PubMed ID: 1419811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different patterns of restriction to B19 parvovirus replication in human blast cell lines.
    Gallinella G; Manaresi E; Zuffi E; Venturoli S; Bonsi L; Bagnara GP; Musiani M; Zerbini M
    Virology; 2000 Dec; 278(2):361-7. PubMed ID: 11118359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined immunocytochemistry and non-isotopic in situ hybridization for the ultrastructural investigation of human parvovirus B19 infection.
    Morey AL; Ferguson DJ; Fleming KA
    Histochem J; 1995 Jan; 27(1):46-53. PubMed ID: 7713756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular localization of parvovirus B19 nucleic acid at the ultrastructural level by in situ hybridization with digoxigenin-labelled probes.
    Morey AL; Ferguson DJ; Leslie KO; Taatjes DJ; Fleming KA
    Histochem J; 1993 Jun; 25(6):421-9. PubMed ID: 8360079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay.
    Bostic JR; Brown KE; Young NS; Koenig S
    J Infect Dis; 1999 Mar; 179(3):619-26. PubMed ID: 9952368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cutaneous manifestations of human parvovirus B19 infection.
    Magro CM; Dawood MR; Crowson AN
    Hum Pathol; 2000 Apr; 31(4):488-97. PubMed ID: 10821497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human parvovirus B19 VP2 empty capsids bind to human villous trophoblast cells in vitro via the globoside receptor.
    Wegner CC; Jordan JA
    Infect Dis Obstet Gynecol; 2004 Jun; 12(2):69-78. PubMed ID: 15739820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental endothelial cells can be productively infected by Parvovirus B19.
    Pasquinelli G; Bonvicini F; Foroni L; Salfi N; Gallinella G
    J Clin Virol; 2009 Jan; 44(1):33-8. PubMed ID: 19058999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unscrambling the role of human parvovirus B19 signaling in systemic autoimmunity.
    Tsay GJ; Zouali M
    Biochem Pharmacol; 2006 Nov; 72(11):1453-9. PubMed ID: 16764828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human parvovirus B19-induced cell cycle arrest and apoptosis.
    Morita E; Sugamura K
    Springer Semin Immunopathol; 2002; 24(2):187-99. PubMed ID: 12503064
    [No Abstract]   [Full Text] [Related]  

  • 13. Generalized petechial eruption induced by parvovirus B19 infection.
    McNeely M; Friedman J; Pope E
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S109-13. PubMed ID: 15858505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parvovirus B19-induced persistent pure red cell aplasia in a child with T-cell immunodeficiency.
    Tavil B; Sanal O; Turul T; Yel L; Gurgey A; Gumruk F
    Pediatr Hematol Oncol; 2009 Mar; 26(2):63-8. PubMed ID: 19322736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parvovirus B19 infections.
    Sabella C; Goldfarb J
    Am Fam Physician; 1999 Oct; 60(5):1455-60. PubMed ID: 10524489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia enhances human B19 erythrovirus gene expression in primary erythroid cells.
    Pillet S; Le Guyader N; Hofer T; NguyenKhac F; Koken M; Aubin JT; Fichelson S; Gassmann M; Morinet F
    Virology; 2004 Sep; 327(1):1-7. PubMed ID: 15327892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human parvovirus B19 non-structural protein (NS1) induces apoptosis through mitochondria cell death pathway in COS-7 cells.
    Hsu TC; Wu WJ; Chen MC; Tsay GJ
    Scand J Infect Dis; 2004; 36(8):570-7. PubMed ID: 15370668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human parvovirus B19 infection and autoimmunity.
    Lunardi C; Tinazzi E; Bason C; Dolcino M; Corrocher R; Puccetti A
    Autoimmun Rev; 2008 Dec; 8(2):116-20. PubMed ID: 18700174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures.
    Zakrzewska K; Cortivo R; Tonello C; Panfilo S; Abatangelo G; Giuggioli D; Ferri C; Corcioli F; Azzi A
    Virus Res; 2005 Dec; 114(1-2):1-5. PubMed ID: 15990190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of parvovirus B19 infection in first and second trimester fetal loss.
    de Krijger RR; van Elsacker-Niele AM; Mulder-Stapel A; Salimans MM; Dreef E; Weiland HT; van Krieken JH; Vermeij-Keers C
    Pediatr Pathol Lab Med; 1998; 18(1):23-34. PubMed ID: 9566279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.